These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32286512)

  • 1. Device-based therapies for arterial hypertension.
    Lauder L; Azizi M; Kirtane AJ; Böhm M; Mahfoud F
    Nat Rev Cardiol; 2020 Oct; 17(10):614-628. PubMed ID: 32286512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current Status of Devices for the Treatment of Resistant Hypertension.
    Kunz M; Lauder L; Ewen S; Böhm M; Mahfoud F
    Am J Hypertens; 2020 Jan; 33(1):10-18. PubMed ID: 31570933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device-Based Neuromodulation for Resistant Hypertension Therapy.
    Lohmeier TE; Hall JE
    Circ Res; 2019 Mar; 124(7):1071-1093. PubMed ID: 30920919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device Therapy of Hypertension.
    Mahfoud F; Schlaich MP; Lobo MD
    Circ Res; 2021 Apr; 128(7):1080-1099. PubMed ID: 33793330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts for patients with treatment-resistant hypertension.
    Eirin A; Textor SC; Lerman LO
    Trends Cardiovasc Med; 2016 Nov; 26(8):700-706. PubMed ID: 27381561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-Based Approaches for the Treatment of Arterial Hypertension.
    Jordan J
    Curr Hypertens Rep; 2017 Jul; 19(7):59. PubMed ID: 28620841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension.
    Groenland EH; Spiering W
    Curr Hypertens Rep; 2020 Mar; 22(4):27. PubMed ID: 32166464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of interventional management of hypertension: threats and opportunities.
    Briasoulis A; Bakris G
    Curr Vasc Pharmacol; 2014 Jan; 12(1):69-76. PubMed ID: 23905592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-based Therapy for Hypertension.
    Ng FL; Saxena M; Mahfoud F; Pathak A; Lobo MD
    Curr Hypertens Rep; 2016 Aug; 18(8):61. PubMed ID: 27370788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular Baroreflex Amplification for Resistant Hypertension.
    van Kleef MEAM; Bates MC; Spiering W
    Curr Hypertens Rep; 2018 May; 20(5):46. PubMed ID: 29744599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Developments and Controversies in the Treatment of Resistant Hypertension.
    Kühl C; Frey N; Frank D
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):178-86. PubMed ID: 27008634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pharmacological methods in the treatment of resistant hypertension.
    Kichukov KN; Dimitrov HV; Nikolova LK; Petrov IS; Tokmakova MP
    Folia Med (Plovdiv); 2012; 54(2):5-11. PubMed ID: 23101278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
    Wallbach M; Koziolek MJ; Wachter R
    Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baroreflex stimulation for treating resistant hypertension: ready for the prime-time?
    Bolignano D; Coppolino G
    Rev Cardiovasc Med; 2018 Sep; 19(3):89-95. PubMed ID: 31054557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Device-Directed Therapy for Resistant Hypertension.
    Tankut SS; Yoruk A; Bisognano JD
    Cardiol Clin; 2017 May; 35(2):255-260. PubMed ID: 28411899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
    Hoppe UC; Brandt MC; Wachter R; Beige J; Rump LC; Kroon AA; Cates AW; Lovett EG; Haller H
    J Am Soc Hypertens; 2012; 6(4):270-6. PubMed ID: 22694986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the heart in blood pressure lowering during chronic baroreflex activation: insight from an in silico analysis.
    Clemmer JS; Pruett WA; Hester RL; Iliescu R; Lohmeier TE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1368-H1382. PubMed ID: 30004810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.